E-Z-EM ships CO(2)ject:
This article was originally published in Clinica
E-Z-EM has begun overseas shipment of its CO(2)ject angiographic injector. The system uses CO(2) as a replacement for the more expensive iodinated contrast media, says the company. E-Z-EM president Daniel Martin claims the company has eliminated the "allergic reactions that can occur with iodinated contrast, with no risk of renal and hepatic toxicity". The use of CO(2) as a contrast medium improves imaging of difficult areas, is less expensive than other agents and less traumatic for the patient, says Mr Martin. The system is undergoing Phases II/III trials in the US and Canada and is already approved in Spain and Australia.